bf/NASDAQ:ATRA_icon.png

COM:ATARABIO

Atara Biotherapeutics Inc

  • Stock

Last Close

10.68

21/11 20:19

Market Cap

44.24M

Beta: -

Volume Today

67.47K

Avg: -

Atara Biotherapeutics, Inc., an off-the-shelf T-cell immunotherapy company, develops treatments for patients with cancer, autoimmune, and viral diseases in the United States. It is developing tabelecleucel, a T-cell immunotherapy that is Phase 3 clinical trials for the treatment of epstein-barr virus (EBV) driven post-transplant lymphoproliferative disease, as well as hematolog...Show More

peer of

competitor of